| Product Code: ETC7625486 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland CNV (Choroidal NeoVascularization) Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland CNV (Choroidal NeoVascularization) Market - Industry Life Cycle |
3.4 Ireland CNV (Choroidal NeoVascularization) Market - Porter's Five Forces |
3.5 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland CNV (Choroidal NeoVascularization) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of age-related macular degeneration (AMD) in Ireland, which is a major cause of choroidal neovascularization (CNV). |
4.2.2 Technological advancements in diagnostic tools and treatment options for CNV. |
4.2.3 Growing awareness among healthcare professionals and patients about the importance of early detection and management of CNV. |
4.3 Market Restraints |
4.3.1 High treatment costs associated with CNV therapies may limit access for some patients. |
4.3.2 Limited availability of specialized healthcare professionals trained in diagnosing and treating CNV in Ireland. |
4.3.3 Regulatory challenges and delays in approval processes for new CNV treatments. |
5 Ireland CNV (Choroidal NeoVascularization) Market Trends |
6 Ireland CNV (Choroidal NeoVascularization) Market, By Types |
6.1 Ireland CNV (Choroidal NeoVascularization) Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Fluorescein AngiographyOptical Coherence Tomography, 2021- 2031F |
6.1.4 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland CNV (Choroidal NeoVascularization) Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Anti-VEGF, 2021- 2031F |
6.2.3 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Photodynamic Therapy, 2021- 2031F |
6.2.4 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Thermal Laser, 2021- 2031F |
6.2.5 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland CNV (Choroidal NeoVascularization) Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.5 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ireland CNV (Choroidal NeoVascularization) Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume, By online Pharmacies, 2021- 2031F |
6.4.5 Ireland CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland CNV (Choroidal NeoVascularization) Market Import-Export Trade Statistics |
7.1 Ireland CNV (Choroidal NeoVascularization) Market Export to Major Countries |
7.2 Ireland CNV (Choroidal NeoVascularization) Market Imports from Major Countries |
8 Ireland CNV (Choroidal NeoVascularization) Market Key Performance Indicators |
8.1 Number of CNV cases diagnosed annually in Ireland. |
8.2 Adoption rate of new CNV treatment technologies in the market. |
8.3 Patient outcomes and quality of life improvements post CNV treatment. |
8.4 Research and development investment in CNV therapies and diagnostic tools. |
8.5 Patient satisfaction and feedback on CNV treatment experiences. |
9 Ireland CNV (Choroidal NeoVascularization) Market - Opportunity Assessment |
9.1 Ireland CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Ireland CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Ireland CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 Ireland CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland CNV (Choroidal NeoVascularization) Market - Competitive Landscape |
10.1 Ireland CNV (Choroidal NeoVascularization) Market Revenue Share, By Companies, 2024 |
10.2 Ireland CNV (Choroidal NeoVascularization) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here